deoxycholic-acid and Rhinitis--Allergic--Seasonal

deoxycholic-acid has been researched along with Rhinitis--Allergic--Seasonal* in 1 studies

Other Studies

1 other study(ies) available for deoxycholic-acid and Rhinitis--Allergic--Seasonal

ArticleYear
Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2014, Volume: 44, Issue:8

    Birch pollen allergy represents the main cause of winter and spring pollinosis in the temperate climate zone of the northern hemisphere and sensitization towards Bet v 1, the major birch pollen allergen, affects over 100 million allergic patients. The major birch pollen allergen Bet v 1 has been described as promiscuous acceptor for a wide variety of hydrophobic ligands.. In search of intrinsic properties of Bet v 1, which account responsible for the high allergenic potential of the protein, we thought to investigate the effects of ligand-binding on immunogenic as well as allergenic properties.. As surrogate ligand of Bet v 1 sodium deoxycholate (DOC) was selected. Recombinant and natural Bet v 1 were characterised physico-chemically as well as immunologically in the presence or absence of DOC, and an animal model of allergic sensitization was established. Moreover, human IgE binding to Bet v 1 was analysed by nuclear magnetic resonance (NMR) spectroscopy.. Ligand-binding had an overall stabilizing effect on Bet v 1. This translated in a Th2 skewing of the immune response in a mouse model. Analyses of human IgE binding on Bet v 1 in mediator release assays revealed that ligand-bound allergen-induced degranulation at lower concentrations; however, in basophil activation tests with human basophils ligand-binding did not show this effect. For the first time, human IgE epitopes on Bet v 1 were determined using antibodies isolated from patients' sera. The IgE epitope mapping of Bet v 1 demonstrated the presence of multiple binding regions.. Deoxycholate binding stabilizes conformational IgE epitopes on Bet v 1; however, the epitopes themselves remain unaltered. Therefore, we speculate that humans are exposed to both ligand-bound and free Bet v 1 during sensitization, disclosing the ligand-binding cavity of the allergen as key structural element.

    Topics: Allergens; Animals; Antigens, Plant; Basophil Degranulation Test; Basophils; Betula; Cell Degranulation; Cell Line; Deoxycholic Acid; Disease Models, Animal; Epitope Mapping; Epitopes; Female; Humans; Immunization; Immunoglobulin E; Ligands; Mice; Models, Molecular; Pollen; Protein Binding; Protein Conformation; Protein Stability; Recombinant Proteins; Rhinitis, Allergic, Seasonal; Thermodynamics

2014